3.30
price up icon13.57%   0.46
 
loading
前日終値:
$2.84
開ける:
$2.96
24時間の取引高:
636.38K
Relative Volume:
1.73
時価総額:
$114.99M
収益:
-
当期純損益:
$-197.68M
株価収益率:
-0.8777
EPS:
-3.76
ネットキャッシュフロー:
$-158.88M
1週間 パフォーマンス:
+47.96%
1か月 パフォーマンス:
-1.66%
6か月 パフォーマンス:
-12.11%
1年 パフォーマンス:
-4.00%
1日の値動き範囲:
Value
$2.84
$3.31
1週間の範囲:
Value
$2.15
$3.31
52週間の値動き範囲:
Value
$1.92
$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
名前
Kodiak Sciences Inc
Name
セクター
Healthcare (1152)
Name
電話
650-281-0850
Name
住所
1200 PAGE MILL RD, PALO ALTO, CA
Name
職員
109
Name
Twitter
@kodiaksciences
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
KOD's Discussions on Twitter

KOD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KOD
Kodiak Sciences Inc
3.285 114.99M 0 -197.68M -158.88M -3.76
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
482.21 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.80 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
603.57 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.64 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-09 アップグレード Jefferies Hold → Buy
2024-09-05 開始されました H.C. Wainwright Neutral
2023-12-11 再開されました Goldman Sell
2023-11-17 アップグレード CapitalOne Equal Weight → Overweight
2023-07-27 ダウングレード UBS Buy → Neutral
2023-07-25 ダウングレード Chardan Capital Markets Buy → Neutral
2023-07-25 ダウングレード JP Morgan Neutral → Underweight
2023-07-24 ダウングレード CapitalOne Overweight → Equal Weight
2023-07-24 ダウングレード Jefferies Buy → Hold
2022-11-15 開始されました CapitalOne Overweight
2022-08-02 ダウングレード Citigroup Neutral → Sell
2022-02-24 ダウングレード JP Morgan Overweight → Neutral
2022-02-11 開始されました Goldman Buy
2022-02-02 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード ROTH Capital Neutral → Buy
2021-03-12 開始されました Evercore ISI Outperform
2021-03-01 ダウングレード Barclays Equal Weight → Underweight
2021-02-17 ダウングレード ROTH Capital Buy → Neutral
2021-01-25 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-12-17 開始されました Berenberg Buy
2020-12-16 開始されました UBS Buy
2020-12-11 開始されました Citigroup Neutral
2020-11-30 ダウングレード JP Morgan Overweight → Neutral
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-13 ダウングレード Goldman Buy → Neutral
2020-03-31 開始されました BMO Capital Markets Outperform
2020-03-03 開始されました Goldman Buy
2020-02-18 ダウングレード Barclays Overweight → Equal Weight
2020-02-06 開始されました SunTrust Buy
2020-01-08 開始されました ROTH Capital Buy
2020-01-03 開始されました Jefferies Buy
2019-12-24 開始されました JP Morgan Overweight
2019-10-15 繰り返されました Chardan Capital Markets Buy
2019-02-20 開始されました Chardan Capital Markets Buy
2018-10-29 開始されました Barclays Overweight
2018-10-29 開始されました BofA/Merrill Buy
2018-10-29 開始されました Morgan Stanley Overweight
すべてを表示

Kodiak Sciences Inc (KOD) 最新ニュース

pulisher
Apr 18, 2025

April 2025's Promising Penny Stocks - Yahoo Finance

Apr 18, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Kodiak Sciences Inc., Outlook Therapeutics, Eye point Pharmaceuticals - The Globe and Mail

Apr 17, 2025
pulisher
Apr 11, 2025

Wet Age-Related Macular Degeneration Therapeutics Market Size - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Sei Investments Co. Sells 69,599 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 09, 2025
pulisher
Apr 04, 2025

Kodiak Sciences stock hits 52-week low at $2.15 - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Comments on Kodiak Sciences Q2 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

HC Wainwright Forecasts Kodiak Sciences Q1 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Sells 6,758 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Kodiak Sciences Advances Retinal Therapies with Promising Pipeline - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Kodiak Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

KODIAK SCIENCES Earnings Results: $KOD Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

Kodiak Sciences Cuts Losses by 26%, Advances Two Phase 3 Trials with $168M War Chest - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

Is Kodiak Sciences Inc. (KOD) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Purchases 4,927 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 26, 2025
pulisher
Mar 24, 2025

Diabetic Macular Edema Pipeline 2025: Therapies Under - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

Kodiak Sciences Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

Critical Contrast: Metagenomi (NASDAQ:MGX) & Kodiak Sciences (NASDAQ:KOD) - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025
pulisher
Mar 19, 2025

Retinal Vein Occlusion Clinical and Non-Clinical Studies, Key - openPR

Mar 19, 2025
pulisher
Mar 18, 2025

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate - MSN

Mar 18, 2025
pulisher
Mar 12, 2025

Diabetic Retinopathy Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 12, 2025
pulisher
Mar 12, 2025

Why Palantir (PLTR) Stock Is Up Today - The Globe and Mail

Mar 12, 2025
pulisher
Mar 10, 2025

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

KODKodiak Sciences Inc. Latest Stock News & Market Updates - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

CDC To Study Vaccines and Autism, Despite Much Research Showing No Link - 69News WFMZ-TV

Mar 10, 2025
pulisher
Mar 10, 2025

Clinical Trial Success: Kodiak Enrolls 250+ Patients for Novel Diabetic Eye Drug - Stock Titan

Mar 10, 2025
pulisher
Mar 04, 2025

Diabetic Retinopathy Pipeline 2025: Mechanism of Action, Route - openPR

Mar 04, 2025
pulisher
Feb 25, 2025

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Yahoo Finance

Feb 25, 2025
pulisher
Feb 23, 2025

Kodiak Sciences’ Anti-VEGF Could Win Nicely On Retinal Disorders (NASDAQ:KOD) - Seeking Alpha

Feb 23, 2025
pulisher
Feb 20, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Large Increase in Short Interest - MarketBeat

Feb 20, 2025
pulisher
Feb 17, 2025

Elisa Oyj (OTCMKTS:ELMUF) Short Interest Update - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Significant Growth in Short Interest - Defense World

Feb 17, 2025
pulisher
Feb 15, 2025

166,843 Shares in Kodiak Sciences Inc. (NASDAQ:KOD) Bought by Peapod Lane Capital LLC - MarketBeat

Feb 15, 2025
pulisher
Feb 12, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 12, 2025
pulisher
Feb 08, 2025

SG Americas Securities LLC Has $209,000 Stock Holdings in Levi Strauss & Co. (NYSE:LEVI) - American Banking and Market News

Feb 08, 2025
pulisher
Feb 08, 2025

SG Americas Securities LLC Has $206,000 Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Feb 08, 2025
pulisher
Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Novartis, Kodiak Sciences Inc., Regenxbio, Perfuse Therapeutics, Hoffmann-La Roche, Boehringer Ingelheim - Barchart

Feb 06, 2025
pulisher
Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion - openPR

Feb 06, 2025
pulisher
Feb 04, 2025

Quarterly Dosing Breakthrough: Kodiak's New Glaucoma Treatment Targets Root Causes - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Kodiak Sciences Inc.'s (NASDAQ:KOD) institutional investors lost 23% over the past week but have profited from longer-term gains - Simply Wall St

Feb 04, 2025

Kodiak Sciences Inc (KOD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.85
price down icon 0.77%
$71.22
price down icon 2.53%
$32.51
price up icon 0.11%
$24.83
price down icon 0.47%
$97.38
price down icon 1.48%
biotechnology ONC
$231.14
price up icon 0.63%
大文字化:     |  ボリューム (24 時間):